Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on May 2, 2025

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)
ORION OYJ PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE 2.5.2025 KLO 15.15 Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Maris-Tech Expands European Reach with New Distribution Agreement in Poland
Collaboration with Armit Addresses Growing Demand for Defense Video …

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss …

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
LEIDEN, Netherlands …

LGI Homes Expands Presence in Polk County with Launch of Peach Crossings in Winter Haven, Florida
WINTER HAVEN, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- LGI Homes is excited to announce the opening of Peach Crossings, a brand-new, 52-lot community now selling in Winter Haven. Nestled in the heart of Polk County, one of Florida’s most desirable and …

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …

CareCloud Announces Preferred Stock Dividend Payments
SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

Dave & Buster’s Announces Board of Directors Transitions
DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Dave …

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the “Merger”) with NeuroMetrix, …

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results
Mt. Olive, NJ, May 02, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCQB: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and …

iBio Reports Fiscal Third Quarter 2025 Financial Results
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq:IBIO), today reported financial results for the third quarter ended March 31, 2025, and provided a corporate update on its progress. “During the third quarter we were able to broaden our access …

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

IREN to Release Q3 FY25 Results on May 14, 2025
SYDNEY, May 02, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, "IREN") today announced that it will release its financial results for the three and nine-months ended March 31, 2025, on Wednesday, May 14, 2025 and host …

SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion
Alexandria, Indiana, May 02, 2025 (GLOBE NEWSWIRE) -- SCROOGE Casino, a pioneering force in purpose-driven social gaming, announced its comprehensive VIP Rakeback Program today, set to debut in May 2025. This initiative arrives as the company continues to …

Trumpcoin ($TRUMP) Surged 30% In April As The Buzz Around Cloud Mining Grew; Investors Seeking Daily Profits With ZA Miner
Middlesex, UK, May 02, 2025 (GLOBE NEWSWIRE) -- Donald Trump is turning up the heat in the crypto space, taking his involvement beyond public statements and into direct digital action. His meme coin, $TRUMP, has recently sparked major attention, shooting …

Melco Announces Earnings Release Date
MACAU, May 02, 2025 (GLOBE NEWSWIRE) -- Melco Resorts …

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
– Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 – – Tourmaline expects to provide further details on the clinical …